Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis

Published:2021-07 Issue:7 Volume:18 Page:1121-1128
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Dempsey Timothy M.¹²^ORCID,Payne Stephanie²,Sangaralingham Lindsey²³,Yao Xiaoxi²⁴⁵,Shah Nilay D.²⁴,Limper Andrew H.¹²

Affiliation:

1. Department of Pulmonary and Critical Care Medicine,

2. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery,

3. OptumLabs, Cambridge, Massachusetts

4. Department of Health Sciences Research, and

5. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; and

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference37 articles.

1. Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis

2. Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis

3. Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan

4. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

5. A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative phytoceutical-based drug delivery in the management of pulmonary fibrosis: A roadmap towards inhaled therapeutics;Journal of Drug Delivery Science and Technology;2024-09

2. Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease;Pharmaceuticals;2024-08-30

3. Use of pirfenidone in fibrotic interstitial lung diseases and beyond: a review;Frontiers in Medicine;2024-08-06

4. The impact of antifibrotic use on long-term clinical outcomes in the pulmonary fibrosis foundation registry;Respiratory Research;2024-06-21

5. Construction and Bioinformatics Analysis of ceRNA Regulatory Networks in Idiopathic Pulmonary Fibrosis;Biochemical Genetics;2024-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3